Division of Translational Cancer Research
501 – 510 of 592
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Mesenchymal Stem Cells
2015) p.762-764(
- Chapter in Book/Report/Conference proceeding › Entry for encyclopaedia/dictionary
-
Mark
Bone Marrow Transplants
2015) p.129-132(
- Chapter in Book/Report/Conference proceeding › Entry for encyclopaedia/dictionary
-
Mark
Drug Testing and Drug Development in Cell Culture
2015) p.363-366(
- Chapter in Book/Report/Conference proceeding › Entry for encyclopaedia/dictionary
-
Mark
Fluorescence-Activated Cell Sorting
2015) p.418-420(
- Chapter in Book/Report/Conference proceeding › Entry for encyclopaedia/dictionary
-
Mark
The PDGFR Receptor Family
2015) p.373-538(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
KIT (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog)
2015)(
- Chapter in Book/Report/Conference proceeding › Entry for encyclopaedia/dictionary
-
Mark
Gene expression of breast cancer related genes in circulating tumour cells (CTCs) from patients with metastatic breast cancer
(
- Contribution to journal › Article
-
Mark
Quantitative imaging by automated bone scan index (BSI) as a response biomarker in standard clinical care of patients with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide
2015) American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium In Journal of Clinical Oncology 33(7 Suppl). p.288-288(
- Contribution to journal › Published meeting abstract
- 2014
-
Mark
SOCS6 is a selective suppressor of receptor tyrosine kinase signaling
(
- Contribution to journal › Scientific review
-
Mark
The HER2-Encoded miR-4728-3p Regulates ESR1 through a Non-Canonical Internal Seed Interaction.
(
- Contribution to journal › Article